Quality statements
Statement 1 Adults with a 5% or more total lifetime risk of developing ovarian cancer have a discussion about risk-reducing surgery. [2025]
Statement 2 Adults aged 40 and over with persistent symptoms that suggest ovarian cancer have an urgent, direct access ultrasound scan of the abdomen and pelvis if indicated by their age and serum CA125 level. [2025, updated 2026]
Statement 3 Adults newly diagnosed with non-mucinous high-grade epithelial ovarian cancer are offered panel germline genetic testing. [2025]
Statement 4 Adults newly diagnosed with stage 3 or 4 non-mucinous high-grade epithelial ovarian cancer are offered tumour genetic testing. [2025]
Statement 5 Adults with high-risk stage 1 ovarian cancer, or stage 2 to 4 ovarian cancer, have both surgery and chemotherapy discussed as a treatment option by a specialist gynaecological cancer multidisciplinary team. [2025]
In 2025, this quality standard was updated, and statements prioritised in 2012 were replaced [2025]. For more information, see update information.
The previous version of the quality standard on ovarian cancer is available as a pdf.